117 related articles for article (PubMed ID: 20621106)
1. A critical pocket close to the glutamate binding site of mGlu receptors opens new possibilities for agonist design.
Acher FC; Selvam C; Pin JP; Goudet C; Bertrand HO
Neuropharmacology; 2011 Jan; 60(1):102-7. PubMed ID: 20621106
[TBL] [Abstract][Full Text] [Related]
2. A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.
Selvam C; Oueslati N; Lemasson IA; Brabet I; Rigault D; Courtiol T; Cesarini S; Triballeau N; Bertrand HO; Goudet C; Pin JP; Acher FC
J Med Chem; 2010 Apr; 53(7):2797-813. PubMed ID: 20218620
[TBL] [Abstract][Full Text] [Related]
3. The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptors.
Rondard P; Goudet C; Kniazeff J; Pin JP; Prézeau L
Neuropharmacology; 2011 Jan; 60(1):82-92. PubMed ID: 20713070
[TBL] [Abstract][Full Text] [Related]
4. Exploration of structure-based drug design opportunities for mGluRs.
Topiol S; Sabio M; Uberti M
Neuropharmacology; 2011 Jan; 60(1):93-101. PubMed ID: 20705075
[TBL] [Abstract][Full Text] [Related]
5. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
[TBL] [Abstract][Full Text] [Related]
6. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
Chen Y; Goudet C; Pin JP; Conn PJ
Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
[TBL] [Abstract][Full Text] [Related]
8. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist.
Schann S; Menet C; Arvault P; Mercier G; Frauli M; Mayer S; Hubert N; Triballeau N; Bertrand HO; Acher F; Neuville P
Bioorg Med Chem Lett; 2006 Sep; 16(18):4856-60. PubMed ID: 16828551
[TBL] [Abstract][Full Text] [Related]
10. Modulation of group III metabotropic glutamate receptors by hydrogen ions.
Levinthal C; Barkdull L; Jacobson P; Storjohann L; Van Wagenen BC; Stormann TM; Hammerland LG
Pharmacology; 2009; 83(2):88-94. PubMed ID: 19065062
[TBL] [Abstract][Full Text] [Related]
11. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor/phospholipase C system in female rat heart.
Iglesias I; Castillo CA; León D; Ruíz MA; Albasanz JL; Martín M
Brain Res; 2007 Jun; 1153():1-11. PubMed ID: 17493590
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
Kew JN
Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
[TBL] [Abstract][Full Text] [Related]
14. The G protein-coupling profile of metabotropic glutamate receptors, as determined with exogenous G proteins, is independent of their ligand recognition domain.
Parmentier ML; Joly C; Restituito S; Bockaert J; Grau Y; Pin JP
Mol Pharmacol; 1998 Apr; 53(4):778-86. PubMed ID: 9547371
[TBL] [Abstract][Full Text] [Related]
15. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
Litschig S; Gasparini F; Rueegg D; Stoehr N; Flor PJ; Vranesic I; Prézeau L; Pin JP; Thomsen C; Kuhn R
Mol Pharmacol; 1999 Mar; 55(3):453-61. PubMed ID: 10051528
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators.
Lundström L; Bissantz C; Beck J; Wettstein JG; Woltering TJ; Wichmann J; Gatti S
Br J Pharmacol; 2011 Sep; 164(2b):521-37. PubMed ID: 21470207
[TBL] [Abstract][Full Text] [Related]
17. Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor.
Pinkerton AB; Vernier JM; Schaffhauser H; Rowe BA; Campbell UC; Rodriguez DE; Lorrain DS; Baccei CS; Daggett LP; Bristow LJ
J Med Chem; 2004 Aug; 47(18):4595-9. PubMed ID: 15317469
[TBL] [Abstract][Full Text] [Related]
18. Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors.
Rovira X; Malhaire F; Scholler P; Rodrigo J; Gonzalez-Bulnes P; Llebaria A; Pin JP; Giraldo J; Goudet C
FASEB J; 2015 Jan; 29(1):116-30. PubMed ID: 25342125
[TBL] [Abstract][Full Text] [Related]
19. [How do G-protein-coupled receptors work? The case of metabotropic glutamate and GABA receptors].
Galvez T; Pin JP
Med Sci (Paris); 2003 May; 19(5):559-65. PubMed ID: 12836389
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
